Table 1 Demographic and clinical characteristics of patients in this study
From: Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis
| Characteristicsa | Patients (n = 70) |
|---|---|
| Sex (Male, %) | 45 (64.3) |
| Age, years (Median, IQR) | 52 (37–65) |
| Residence | |
| Rural | 30 (42.9) |
| Urban | 40 (57.1) |
| Pre-existing disease | |
| Any pre-existing disease | 38 (54.3) |
| Cardiovascular disease | 21 (30.0) |
| Endocrine disease | 12 (17.1) |
| Neurological disease | 6 (8.6) |
| Rental disease | 4 (5.7) |
| Respiratory disease | 3 (4.3) |
| Liver disease | 1 (1.4) |
| Malignancy | 1 (1.4) |
| Disease Severity | |
| Mild | 55 (78.6) |
| Severe | 4 (5.7) |
| Critically ill | 11 (15.7) |
| Drug acquisition | |
| Antivirus | 69 (98.6) |
| Antibiotic | 43 (61.4) |
| Antifungal | 8 (11.4) |
| Immunomodulator | 63 (90.0) |
| Pre-existing diseases | 38 (54.3) |
| Chinese medicine | 70 (100.0) |
| Clinical outcomes | |
| Cure | 67 (95.7) |
| Died | 3 (4.3) |
| Duration of hospitalization, days (Median, IQR) | 16 (10–23) |